Mrs Juliane Meyerhoff
Boehringer Ingelheim GmbH&Co KG, Ingelheim (Germany)
Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Anticoagulation in atrial fibrillation II
ESC 365 is supported by
